eRAPID:癌症治疗期间患者自报与管理不良事件的整合电子平台
本文介绍由英国国家卫生研究院资助的eRAPID系统的开发过程,该系统让患者在癌症治疗期间及之后在线自报并管理不良事件。多学科团队基于敏捷原则在QStore与QTool基础上构建实时ePRO界面,并开发对应CTCAE分级的层级算法。系统可对轻中度AE给出自我管理建议、对严重AE提示立即联系医院,临床医生可在电子病历中查看数据并收到严重AE邮件通知。
要点
- 患者可通过PC、平板或任意联网设备在家中安全自报不良事件。
- 系统对低或中度AE即时生成自我管理建议,对严重AE提示立即联系医院。
- 临床医生可在电子病历中查看患者AE数据,患者报告严重AE时收到邮件通知。
核心结论
- eRAPID系统支持患者在癌症治疗期间居家自报AE,并为轻中度AE提供自我管理建议、为严重AE提供立即联系医院的建议,临床医生可在电子病历中查看数据并接收严重AE邮件通知。
- 该系统正在乳腺癌、妇科和结直肠癌接受全身治疗的患者中开展随机对照试验评估。
- 为适配不同治疗人群,正在接受盆腔放疗和上消化道手术的患者中开展试点研究。
研究设计与样本
- 由IT专家、工作人员和患者组成的多学科团队基于敏捷原则开发,在现有在线问卷构建器QTool之上构建安全网络应用接口QStore,将实时ePRO数据呈现于Leeds Teaching Hospitals NHS Trust的电子病历中。
- 利用QTool问题依赖功能开发了对应常见不良事件术语标准(CTCAE)分级的层级算法。
- 患者倡导者(N=9)、患者(N=13)和工作人员(N=19)对系统进行了可用性测试,报告了多种AE组合。
主要发现
- 患者可在治疗期间通过PC、平板或任意联网设备在家中安全自报AE。
- 系统对低或中度AE即时生成自我管理建议,对严重AE生成立即联系医院的建议。
- 临床医生可在电子病历中查看患者AE数据,并在患者报告严重AE时收到邮件通知。
临床怎么用
- 该系统旨在通过电子PRO实时向临床医生提供可及记录以指导治疗决策,改善医患沟通。
- 系统按CTCAE分级对应的层级算法,对低或中度AE给出自我管理建议,对严重AE提示立即联系医院。
- 临床医生通过电子病历查看患者AE数据,并接收严重AE的邮件通知。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Significant adverse events (AE) during cancer therapy disrupt treatment and escalate to emergency admissions. Approaches to improve the timeliness and accuracy of AE reporting may improve safety and reduce health service costs. Reporting AE via patient reported outcomes (PROs), can improve clinician-patient communication and making data available to clinicians in 'real-time' using electronic PROs (ePROs) could potentially transform clinical practice by providing easily accessible records to guide treatment decisions. This manuscript describes the development of eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and aDvice) is a National Institute for Health Research-funded programme, a system for patients to self-report and manage AE online during and after cancer treatment. MATERIALS AND METHODS: A multidisciplinary team of IT experts, staff and patients developed using agile principles a secure web application interface (QStore) between an existing online questionnaire builder (QTool) displaying real-time ePRO data to clinicians in the electronic patient record at Leeds Teaching Hospitals NHS Trust. Hierarchical algorithms were developed corresponding to Common Terminology Criteria for Adverse Events grading using the QTool question dependency function. Patient advocates (N = 9), patients (N = 13), and staff (N = 19) usability tested the system reporting combinations of AE. RESULTS: The eRAPID system allows patients to report AE from home on PC, tablet or any web enabled device securely during treatment. The system generates immediate self-management advice for low or moderate AE and for severe AE advice to contact the hospital immediately. Clinicians can view patient AE data in the electronic patient record and receive email notifications when patients report severe AE. CONCLUSIONS: Evaluation of the system in a randomised controlled trial in breast, gynaecological and colorectal cancer patients undergoing systemic therapy is currently underway. To adapt eRAPID for different treatment groups, pilot studies are being undertaken with patients receiving pelvic radiotherapy and upper gastrointestinal surgery. ISRCTN88520246.
引用
- Holch P, Warrington L, Bamforth LCA, et al. Development of an integrated electronic platform for patient self-report and management of adverse events during cancer treatment. Ann Oncol. 2017. PMID: 28911065. doi:10.1093/annonc/mdx317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。